These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 5486763)

  • 1. [Prophylaxis in hemophilia].
    Ortega F; Martin-Villar J; Navarro JL
    Sangre (Barc); 1970; 15(3):355-61. PubMed ID: 5486763
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide.
    Nilsson IM; Hedner U; Holmberg L
    Acta Med Scand; 1974; 195(1-2):64-72. PubMed ID: 4817094
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of hemorrhage in patients with hemophilia].
    Pliushch OP; Rutberg RA; Zakhrova NS; Shefter LI
    Probl Gematol Pereliv Krovi; 1976 Jan; 21(1):11-3. PubMed ID: 1273055
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hemophilia A with actor VIII concentrate in urological operations and injuries of the urinary tract].
    Brühl P; Weibbach L; Brackmann HH
    MMW Munch Med Wochenschr; 1975 Mar; 117(10):401-4. PubMed ID: 804604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis in children with hemophilia: is it the optimal treatment?
    Lusher JM
    Thromb Haemost; 1997 Jul; 78(1):726-9. PubMed ID: 9198246
    [No Abstract]   [Full Text] [Related]  

  • 6. Experience with prophylaxis in Sweden.
    Nilsson IM
    Semin Hematol; 1993 Jul; 30(3 Suppl 2):16-9. PubMed ID: 8367738
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
    Duckert F; Müller G; Meili EO
    Schweiz Med Wochenschr; 1971 Dec; 101(50):1831-8. PubMed ID: 5173501
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight(®) ) in previously treated patients with severe haemophilia A: interim results of the guardian(™) 2 extension trial.
    Ozelo M; Misgav M; Abdul Karim F; Lentz SR; Martin-Salces M; Matytsina I; Saugstrup T; Santagostino E
    Haemophilia; 2015 Sep; 21(5):e436-9. PubMed ID: 26058730
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic treatment of factor VIII deficiency.
    Hirschman RJ; Itscoitz SB; Shulman NR
    Blood; 1970 Feb; 35(2):189-94. PubMed ID: 5308870
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment and prophylaxis of arthropathy in severe hemophilia.
    Ahlberg A
    Clin Orthop Relat Res; 1967; 53():135-46. PubMed ID: 5586853
    [No Abstract]   [Full Text] [Related]  

  • 11. Can hemophilic patients be adequately maintained with cryoprecipitates? Or is it desirable or even necessary to manufacture and administer highly concentrated AHF products?
    Vox Sang; 1972; 22(6):554-65. PubMed ID: 5050492
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental prophylaxis of severe hemophilia with a factor VIII concentrate.
    Shanbrom E; Thelin GM
    JAMA; 1969 Jun; 208(10):1853-6. PubMed ID: 5818829
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of fraction I for oral surgical procedures in patients with classic hemophilia: report of seven cases.
    Marder VJ; Gamble JW; Shulman NR
    J Oral Surg; 1966 Nov; 24(6):487-99. PubMed ID: 5296941
    [No Abstract]   [Full Text] [Related]  

  • 14. [Side-effects of factor VIII substitution in patients with hemophilia A (author's transl)].
    Tilsner V; Reuter H
    MMW Munch Med Wochenschr; 1982 Jun; 124(22):553-7. PubMed ID: 6808385
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of fraction C-1 in children with hemophilia A].
    Kamińska D; Adamowicz-Salach A; Pytel Z
    Pediatr Pol; 1985 Jan; 60(1):65-8. PubMed ID: 3929224
    [No Abstract]   [Full Text] [Related]  

  • 16. [A case of urinary tract hemorrhage in a child with hemophilia A treated with cryoprecipitate AHG].
    Foltyn H; Wróbel I
    Pediatr Pol; 1969 Sep; 44(9):1155-7. PubMed ID: 5364502
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor VIII usage in the Wisconsin Hemophilia Program; factor VIII usage in hemophilia.
    Lange D; Lazerson J
    Wis Med J; 1982 Feb; 81(2):28-31. PubMed ID: 6803446
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of porcine factor VIII in Japan.
    Yoshioka A; Shima M; Morichika S; Terada S; Fukui H
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):26-8. PubMed ID: 7939769
    [No Abstract]   [Full Text] [Related]  

  • 19. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A; Zieleniewska B
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Opportune treatment of hemorrhage in classical hemophilia. Study of the Hemophilia Cooperative Group].
    Rodríguez-Moyado H; Ambriz-Fernández R; Pizzuto-Chávez J; Farfán-Canto JM; Hernández-Lugo MI; Guillén-Mariscal C; Ramírez-Ortiz G; Benítez-Aranda H
    Bol Med Hosp Infant Mex; 1986 Dec; 43(12):742-9. PubMed ID: 3101718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.